LASTET Side Effects

6101687-8 | Bone Marrow Failure, Prostatic Abscess, Pseudomonas Infection, Pyrexia, White Blood Cell Count Decreased
on Feb 26, 2009 Male patient from JAPAN , 22 years of age, was diagnosed with testicular cancer metastatic and was treated with Lastet (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, prostatic abscess, pseudomonas infection, pyrexia, white blood cell count decreased. Lastet dosage: Administered On Days 1 To 5. During the same period patient was treated with RANDA (Administered On Days 1 To 5) (View Randa Review and Randa Label ), BLEOMYCIN SULFATE (Administered On 2, 9 And 18) (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ).

5842914-1 | Bone Marrow Failure, Organising Pneumonia, Pulmonary Fibrosis
Patient was taking Lastet (View Usage). Patient had the following side effects: bone marrow failure, organising pneumonia, pulmonary fibrosis (What is pulmonary fibrosis?) on Aug 11, 2008 from JAPAN Additional patient health information: Male patient , 26 years of age, was diagnosed with testis cancer and. Lastet dosage: . During the same period patient was treated with BLEO (Started On 15-oct-07) (View Bleo Review and Bleo Label ), RANDA (Started On 15-oct-07) (View Randa Review and Randa Label ), FIRSTCIN (View Firstcin Review and Firstcin Label ), PANSPORIN (View Pansporin Review and Pansporin Label ), PRODIF (View Prodif Review and Prodif Label ), MINOCYCLINE HCL (View Minocycline Hcl Review and Minocycline Hcl Label ), FUNGUARD (View Funguard Review and Funguard Label ), PASIL (View Pasil Review and Pasil Label ).

5796479-3 | Interstitial Lung Disease
Adverse event was reported on Jun 30, 2008 by a Male patient taking Lastet (View Usage) (Dosage: 1st+2nd Cycle:180mg/day, Total 900mg Between 26jun-2jul + 25jul-29jul In 2006) was diagnosed with extragonadal primary germ cell cancer and. Location: JAPAN , 34 years of age, After Lastet was administered, patient had the following side effects: interstitial lung disease. During the same period patient was treated with BRIPLATIN (1st+2nd Cycle:35mg/day,total 175mg Between 26jun-2jul06 + 25jul-29jul06.) (View Briplatin Review and Briplatin Label ), BLEOMYCIN HCL (1st+2nd Cycle:30mg/day, Total 90mg Between 26jun-12jul06 + 25jul-14aug06.) (View Bleomycin Hcl Review and Bleomycin Hcl Label ). Patient was hospitalized.

5781732-X | Bone Marrow Failure, Cryptogenic Organising Pneumonia, Pulmonary Fibrosis
on Jun 18, 2008 Male patient from JAPAN , 26 years of age, was diagnosed with testis cancer and was treated with Lastet (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, cryptogenic organising pneumonia, pulmonary fibrosis (What is pulmonary fibrosis?). Lastet dosage: . During the same period patient was treated with BLEO (Started On 15-oct-07) (View Bleo Review and Bleo Label ), RANDA (Started On 15-oct-07) (View Randa Review and Randa Label ), FIRSTCIN (View Firstcin Review and Firstcin Label ), PANSPORIN (View Pansporin Review and Pansporin Label ), PRODIF (View Prodif Review and Prodif Label ), MINOCYCLINE HCL (View Minocycline Hcl Review and Minocycline Hcl Label ), FUNGUARD (View Funguard Review and Funguard Label ), PASIL (View Pasil Review and Pasil Label ).


5773704-6 | Interstitial Lung Disease
on Jun 11, 2008 Male patient from JAPAN , 34 years of age, was diagnosed with extragonadal primary germ cell cancer and was treated with Lastet (View Usage). Patient had the following side effects: interstitial lung disease. Lastet dosage: 1st+2nd Cycle:180mg/day, Total 900mg Between 26jun-2jul + 25jul-29jul In 2006. During the same period patient was treated with BRIPLATIN (1st+2nd Cycle:35mg/day,total 175mg Between 26jun-2jul06 + 25jul-29jul06.) (View Briplatin Review and Briplatin Label ), BLEOMYCIN HCL (1st+2nd Cycle:30mg/day, Total 90mg Between 26jun-12jul06 + 25jul-14aug06.) (View Bleomycin Hcl Review and Bleomycin Hcl Label ).

5737925-0 | Cryptogenic Organising Pneumonia, Pulmonary Fibrosis
Patient was taking Lastet (View Usage). After Lastet was administered, patient had the following side effects: cryptogenic organising pneumonia, pulmonary fibrosis (What is pulmonary fibrosis?) on May 12, 2008 from JAPAN Additional patient health information: Male patient , 26 years of age, was diagnosed with testis cancer and. Lastet dosage: . During the same period patient was treated with BLEO (Started On 15-oct-07) (View Bleo Review and Bleo Label ), RANDA (Started On 15-oct-07) (View Randa Review and Randa Label ), FIRSTCIN (View Firstcin Review and Firstcin Label ), PANSPORIN (View Pansporin Review and Pansporin Label ), PRODIF (View Prodif Review and Prodif Label ), MINOCYCLINE HCL (View Minocycline Hcl Review and Minocycline Hcl Label ), FUNGUARD (View Funguard Review and Funguard Label ), PASIL (View Pasil Review and Pasil Label ).

5721397-6 | Pulmonary Fibrosis
Adverse event was reported on Apr 24, 2008 by a Male patient taking Lastet (View Usage) (Dosage: ) was diagnosed with testis cancer and. Location: JAPAN , 26 years of age, Patient experienced the following unwanted or unexpected effects: pulmonary fibrosis (What is pulmonary fibrosis?). During the same period patient was treated with BLEO (View Bleo Review and Bleo Label ), RANDA (View Randa Review and Randa Label ).

5513951-1 | Blood Creatine Phosphokinase Increased, Myalgia
on Nov 02, 2007 Male patient from UNITED STATES , 19 years of age, was diagnosed with testis cancer and was treated with Lastet (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, myalgia. Lastet dosage: . During the same period patient was treated with IFOMIDE (View Ifomide Review and Ifomide Label ), RANDA (View Randa Review and Randa Label ).

5362009-3 | Neutropenia
on Jun 14, 2007 Female patient from JAPAN , 55 years of age, was diagnosed with ovarian neoplasm and was treated with Lastet (View Usage). After Lastet was administered, patient had the following side effects: neutropenia. Lastet dosage: . During the same period patient was treated with BLEOMYCIN (View Bleomycin Review and Bleomycin Label ), RANDA (View Randa Review and Randa Label ), KYTRIL (View Kytril Review and Kytril Label ).

5267637-1 | Azoospermia
Patient was taking Lastet (View Usage). Patient experienced the following unwanted or unexpected effects: azoospermia on Mar 05, 2007 from JAPAN Additional patient health information: Male patient , 32 years of age, was diagnosed with testis cancer and. Lastet dosage: . During the same period patient was treated with BLEOMYCIN (View Bleomycin Review and Bleomycin Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), RANDA (View Randa Review and Randa Label ).

5267557-2 | Azoospermia
Adverse event was reported on Mar 05, 2007 by a Male patient taking Lastet (View Usage) (Dosage: ) was diagnosed with testis cancer and. Location: JAPAN , 32 years of age, Patient had the following side effects: azoospermia. During the same period patient was treated with BLEOMYCIN (View Bleomycin Review and Bleomycin Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), RANDA (View Randa Review and Randa Label ).

5044411-2 | Bone Marrow Failure, Bone Sarcoma, Dyspnoea, Treatment Related Secondary Malignancy
on May 31, 2006 Male patient from JAPAN , child 5 years of age, was diagnosed with retinoblastoma bilateral and was treated with Lastet (View Usage). After Lastet was administered, patient had the following side effects: bone marrow failure, bone sarcoma, dyspnoea, treatment related secondary malignancy. Lastet dosage: . During the same period patient was treated with PARAPLATIN (View Paraplatin Review and Paraplatin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), PIRARUBICIN HCL (View Pirarubicin Hcl Review and Pirarubicin Hcl Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), MABLIN (View Mablin Review and Mablin Label ), THIOTEPA (View Thiotepa Review and Thiotepa Label ).

5044404-5 | Bone Sarcoma
on Jun 21, 2006 Male patient from UNITED STATES , child 5 years of age, was diagnosed with retinoblastoma and was treated with Lastet (View Usage). Patient experienced the following unwanted or unexpected effects: bone sarcoma. Lastet dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), THERARUBICIN (View Therarubicin Review and Therarubicin Label ), ALKERAN (View Alkeran Review and Alkeran Label ), MABLIN (View Mablin Review and Mablin Label ), THIOTEPA (View Thiotepa Review and Thiotepa Label ).

5039473-2 | Bone Sarcoma
Patient was taking Lastet (View Usage). Patient had the following side effects: bone sarcoma on Jun 21, 2006 from UNITED STATES Additional patient health information: Male patient , child 5 years of age, was diagnosed with retinoblastoma and. Lastet dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), THERARUBICIN (View Therarubicin Review and Therarubicin Label ), ALKERAN (View Alkeran Review and Alkeran Label ), MABLIN (View Mablin Review and Mablin Label ), THIOTEPA (View Thiotepa Review and Thiotepa Label ).

4779705-9 | Disseminated Intravascular Coagulation, Peritonitis, White Blood Cell Count Decreased
Adverse event was reported on Aug 19, 2005 by a Female patient taking Lastet (View Usage) (Dosage: ) was diagnosed with lymphoma (What is lymphoma?) and. Location: UNITED STATES , 71 years of age, After Lastet was administered, patient had the following side effects: disseminated intravascular coagulation, peritonitis, white blood cell count decreased. During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), PINORUBIN (View Pinorubin Review and Pinorubin Label ), RITUXAN (View Rituxan Review and Rituxan Label ), PREDONINE (View Predonine Review and Predonine Label ).

4603673-3 | Sick Sinus Syndrome, Ventricular Extrasystoles
on Jan 14, 2005 Male patient from , 47 years of age, was diagnosed with testis cancer, prophylaxis, prophylaxis against gastrointestinal ulcer, analgesic effect, infection prophylaxis and was treated with Lastet (View Usage). Patient experienced the following unwanted or unexpected effects: sick sinus syndrome, ventricular extrasystoles. Lastet dosage: . During the same period patient was treated with IFOMIDE (View Ifomide Review and Ifomide Label ), UROMITEXAN (View Uromitexan Review and Uromitexan Label ), PARAPLATIN (View Paraplatin Review and Paraplatin Label ), ZANTAC (View Zantac Review and Zantac Label ), FENTANYL (5-10 Mg/3per Day) (View Fentanyl Review and Fentanyl Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ), DIAMOX (13-sep-2004 To 18-sep-2004 26-sep-2004 To 30-sep-2004) (View Diamox Review and Diamox Label ), FUNGIZONE (View Fungizone Review and Fungizone Label ).

4560188-9 | Sick Sinus Syndrome, Ventricular Extrasystoles
on Jan 14, 2005 Male patient from , 47 years of age, was diagnosed with testis cancer, prophylaxis, prophylaxis against gastrointestinal ulcer, analgesic effect, infection prophylaxis and was treated with Lastet (View Usage). Patient had the following side effects: sick sinus syndrome, ventricular extrasystoles. Lastet dosage: . During the same period patient was treated with IFOMIDE (View Ifomide Review and Ifomide Label ), UROMITEXAN (View Uromitexan Review and Uromitexan Label ), PARAPLATIN (View Paraplatin Review and Paraplatin Label ), ZANTAC (View Zantac Review and Zantac Label ), DUROTEP (5-10 Mg/3per Day) (View Durotep Review and Durotep Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ), DIAMOX (13-sep-2004 To 18-sep-2004 26-sep-2004 To 30-sep-2004) (View Diamox Review and Diamox Label ), FUNGIZONE (View Fungizone Review and Fungizone Label ).

4559012-X | Acute Myeloid Leukaemia, Cerebellar Tumour, Cerebral Haemorrhage, Gingival Bleeding, Haemorrhagic Diathesis, Myelodysplastic Syndrome, Petechiae, T-cell Lymphoma, Treatment Related Secondary Malignancy
Patient was taking Lastet (View Usage). After Lastet was administered, patient had the following side effects: acute myeloid leukaemia, cerebellar tumour, cerebral haemorrhage, gingival bleeding, haemorrhagic diathesis, myelodysplastic syndrome, petechiae, t-cell lymphoma, treatment related secondary malignancy on Sep 09, 2004 from Additional patient health information: Female patient , 41 years of age, was diagnosed with acute myeloid leukaemia and. Lastet dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), BLEOMYCIN (View Bleomycin Review and Bleomycin Label ), PARAPLATIN (View Paraplatin Review and Paraplatin Label ), RANDA (View Randa Review and Randa Label ), ADRIACIN (View Adriacin Review and Adriacin Label ), ONCOVIN (View Oncovin Review and Oncovin Label ). Patient was hospitalized.

4546090-7 | Blood Pressure Decreased, Metastases To Bone, Metastasis, Neutropenia, Pancytopenia, Pneumonia, Pyrexia
Adverse event was reported on Jul 23, 2004 by a Male patient taking Lastet (View Usage) (Dosage: ) was diagnosed with ewing's sarcoma and. Location: , 50 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, metastases to bone, metastasis, neutropenia, pancytopenia, pneumonia (What is pneumonia?), pyrexia. During the same period patient was treated with IFOMIDE (View Ifomide Review and Ifomide Label ), ADRIACIN (View Adriacin Review and Adriacin Label ).